AI-driven drug discovery’s rapid progression to human trials could revolutionize biotech timelines, potentially accelerating medical advancements.
The post Absci Corporation progresses ABS-201 into human trials, bolstering AI-driven drug discovery appeared first on Crypto Briefing.
Source: https://cryptobriefing.com/absci-abs-201-ai-drug-discovery-human-trials/
NEAR is betting that AI agents will transact on-chain at machine speed and need a blockchain built for them. The thesis, the June upgrade, and the catch.
In BlackRock Bitcoin news today, three-quarters of investors in BlackRock’s iShares Bitcoin Trust ETF had never owned an ETF before buying it, and once inside, many began buying S&P 500 funds, gold ETFs, and AI products from the same issuer. The narrative was always that Wall Street money would flow into crypto through these wrappers.…
Ethereum has remained a mystery in terms of price movements on a macro scale, as it trades at essentially the same level as it did in March 2021. Nevertheless, two of the most popular crypto analysts on X outlined a major breakout path forward that could take it toward its all-time high level. However, there’s…
